Pathology confirmed an invasive ductal carcinoma, moderately differentiated, 2.4 cm, estrogen/progesterone receptor negative, HER2/neu negative, with negative surgical margins. The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.